BAP1 deficient human and mouse uveal melanomas up-regulate a shared EMT pathway
Farag, R.; Jain, F.; Luty, A.; Longakit, A. N.; Van Raamsdonk, C. D.
Show abstract
Monosomy 3 is a negative indicator for uveal melanoma (UM). A key tumor suppressor on chromosome 3 is the deubiquitinase BAP1, which usually has a second hit in cases with monosomy 3. Here, we investigated the role of Bap1 loss in the GNAQQ209L mouse UM model. We found that heterozygous Bap1 mutations increased the proportion of lung lesions reaching an unusually large size and permitted the growth of liver lesions. Comparison of RNAseq data from mouse and human UM identified a set of 270 genes differentially expressed in the same direction when BAP1 is mutant. The most significant pathway in this gene set was Epithelial to Mesenchymal Transition (EMT). The expression of five apical junction complex genes known to be down-regulated in association with EMT was very significantly correlated with survival in human UM patients. Activation of EMT through Bap1 deficiency could increase melanoma plasticity and adaptation to new microenvironments.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.